Old Web
English
Sign In
Acemap
>
authorDetail
>
Pablo Berlanga
Pablo Berlanga
Institut Gustave Roussy
Medicine
Oncology
Temozolomide
Internal medicine
genetic variants
4
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
First-in-child phase I/II study of the dual mTORC1/2 inhibitor vistusertib (AZD2014) as monotherapy and in combination with topotecan-temozolomide in children with advanced malignancies: arms E and F of the AcSé-ESMART trial.
2021
European Journal of Cancer
Raphael J. Morscher
Caroline Brard
Pablo Berlanga
Lynley V. Marshall
Nicolas André
Jonathan Rubino
Isabelle Aerts
Emilie De Carli
Nadège Corradini
Souad Nebchi
Xavier Paoletti
Peter G. Mortimer
Ludovic Lacroix
Gaëlle Pierron
G Schleiermacher
Gilles Vassal
Birgit Geoerger
Show All
Source
Cite
Save
Citations (0)
Mineral and Bone Consequences of High Dose Denosumab Therapy to Treat an Aneurysmal Bone Cyst, a Child Case Report.
2021
Frontiers in Endocrinology
Giulia Del Sindaco
Pablo Berlanga
Laurence Brugières
Eric Thebault
Giovanna Mantovani
Philippe Wicart
Agnès Linglart
Show All
Source
Cite
Save
Citations (0)
Clinical and molecular analysis of smoothened inhibitors in Sonic Hedgehog medulloblastoma.
2021
Victor Pereira
Jacob Torrejon
Dulanjalee Kariyawasam
Pablo Berlanga
Lea Guerrini-Rousseau
Olivier Ayrault
Pascale Varlet
Arnault Tauziède-Espariat
Stéphanie Puget
Stéphanie Bolle
Kevin Beccaria
Thomas Blauwblomme
Laurence Brugières
Jacques Grill
Birgit Geoerger
Christelle Dufour
Samuel Abbou
Show All
Source
Cite
Save
Citations (0)
Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next?
2021
International Journal of Molecular Sciences
Gladys Olivera
Andrea Urtasun
Luis Sendra
Salvador F. Aliño
Yania Yáñez
Vanessa Segura
Pablo Gargallo
Pablo Berlanga
Victoria Castel
Adela Cañete
María José Herrero
Show All
Source
Cite
Save
Citations (0)
1